Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium (myfortic®) in a patient with graft-versus-host disease

被引:0
作者
Kuhnowski F. [1 ]
Terriou L. [1 ]
Magro L. [1 ]
Jouet J.-P. [1 ]
Yakoub-Agha I. [1 ]
机构
[1] Service des Maladies du Sang, UAM Allogreffes de CSH, CHRU, Lille
关键词
Imatinib; Tacrolimus; Chronic Myeloid Leukaemia; Mycophenolate Mofetil; Busulfan;
D O I
10.2165/00003495-200666002-00009
中图分类号
学科分类号
摘要
[No abstract available]
引用
收藏
页码:29 / 31
页数:2
相关论文
共 50 条
  • [21] Sites of gastrointestinal lesion induced by mycophenolate mofetil: a comparison with enteric-coated mycophenolate sodium in rats
    Yichen Jia
    Rulin Wang
    Long Li
    Ying Zhang
    Jiawei Li
    Jina Wang
    Xuanchuan Wang
    Guisheng Qi
    Ruiming Rong
    Ming Xu
    Tongyu Zhu
    BMC Pharmacology and Toxicology, 19
  • [22] Long-term safety and efficacy after conversion of maintenance renal transplant recipients from mycophenolate mofetil (MMF) to enteric-coated mycophenolate sodium (EC-MPA, myfortic®)
    Budde, K.
    Knoll, G.
    Curtis, J.
    Chan, L.
    Pohanka, E.
    Gentil, M.
    Seifu, Y.
    Marrast, A. -C.
    Neumayer, H. -H.
    CLINICAL NEPHROLOGY, 2006, 66 (02) : 103 - 111
  • [23] Effect of conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium on maximum tolerated dose and gastrointestinal symptoms following kidney transplantation
    Shehata, Magdi
    Bhandari, Sunil
    Venkat-Raman, Gopalakrishnan
    Moore, Richard
    D'Souza, Richard
    Riad, Hany
    Bakran, Ali
    Baker, Richard
    Needham, Christine
    Andrews, Christopher
    TRANSPLANT INTERNATIONAL, 2009, 22 (08) : 821 - 830
  • [24] Efficacy of mycophenolate mofetil in the treatment of chronic graft-versus-host disease
    Lopez, F
    Parker, P
    Nademanee, A
    Rodriguez, RT
    Al-Kadbimi, Z
    Bhatia, R
    Cohen, S
    Falk, P
    Fung, H
    Kirschbaum, M
    Krishnan, A
    Kogut, N
    Molina, A
    Nakamura, R
    O'Donnell, M
    Popplewell, L
    Pullarkat, V
    Rosenthal, P
    Sahebi, F
    Smith, E
    Snyder, D
    Somlo, G
    Spielberger, R
    Stein, A
    Sweetman, R
    Zain, J
    Forman, S
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (04) : 307 - 313
  • [25] Improved Gastrointestinal Symptoms and Quality of Life after Conversion from Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium in Renal Transplant Patients Receiving Tacrolimus
    Hwang, Hyeon Seok
    Hyoung, Bok Jin
    Kim, Sol
    Oh, Ha Young
    Kim, Yon Su
    Kim, Jung Kyung
    Kim, Yeong Hoon
    Kim, Yong Lim
    Kim, Chan Duck
    Shin, Gyu Tae
    Yang, Chul Woo
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2010, 25 (12) : 1759 - 1765
  • [26] Comparing Outcomes Associated With Dose Manipulations of Enteric-Coated Mycophenolate Sodium Versus Mycophenolate Mofetil in Renal Transplant Recipients
    Cooper, Matthew
    Deering, Kathleen L.
    Slakey, Douglas P.
    Harshaw, Qing
    Arcona, Stephen
    McCann, Erin L.
    Rasetto, Flavia A.
    Florman, Sander S.
    TRANSPLANTATION, 2009, 88 (04) : 514 - 520
  • [27] Patient-reported gastrointestinal symptom burden and health-related quality of life following conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium
    Chan, Laurence
    Mulgaonkar, Shamkant
    Walker, Rowan
    Arns, Wolfgang
    Ambuehl, Patrice
    Schlavelli, Ruben
    TRANSPLANTATION, 2006, 81 (09) : 1290 - 1297
  • [28] Enteric-coated mycophenolate sodium is therapeutically equivalent to mycophenolate mofetil in de novo renal transplant patients
    Salvadori, M
    Holzer, H
    de Mattos, A
    Sollinger, H
    Arns, W
    Oppenheimer, F
    Maca, J
    Hall, M
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (02) : 231 - 236
  • [29] Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in maintenance renal transplant recipients receiving tacrolimus:: Clinical, pharmacokinetic, and pharmacodynamic outcomes
    Budde, Klemens
    Glander, Petra
    Kraemer, Bernhard K.
    Fischer, Wolfgang
    Hoffmann, Ute
    Bauer, Steffen
    Grohmann, Jana
    Neumayer, Hans-Hellmut
    Arns, Wolfgang
    TRANSPLANTATION, 2007, 83 (04) : 417 - 424
  • [30] Salvage therapy for refractory chronic graft-versus-host disease with mycophenolate mofetil and tacrolimus
    B Mookerjee
    V Altomonte
    G Vogelsang
    Bone Marrow Transplantation, 1999, 24 : 517 - 520